Inhibitory effect of troglitazone on TNF-α-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells

Diabetes Research and Clinical Practice

Volumn 48, Issue 3, 2000, Pages 171-176

  Ohta, Masayoshi Y ^a   Nagai, Yukihiro ^a   Takamura, Toshinari ^a   Nohara, Erika ^a   Kobayashi, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Endothelial cells; MCP 1; TNF ; Troglitazone

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MONOCYTE; NORTHERN BLOTTING; PROTEIN EXPRESSION;

CELLS, CULTURED; CHEMOKINE CCL2; CHROMANS; ENDOTHELIUM, VASCULAR; HUMANS; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0034009631     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00128-5     Document Type: Article

References (30)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1998;1595-1607.
2. Moller D.E., Flier J.S. Insulin resistance: mechanisms, syndromes and implications. N. Engl. J. Med. 324:1991;938-948.
3. Kumar S., Boulton A.J.M., Beck-Nielsen H. et al. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia. 39:1996;701-709.
4. Nagasaka Y., Kaku K., Nakamura K. et al. The new oral hypoglycemic agent, CS-045, inhibits the lipid peroxidation of human plasma low-density lipoprotein in vitro. Biochem. Pharmacol. 50:1995;1109-1111.
5. Noguchi N., Sakai H., Kato Y. et al. Inhibition of oxidation of low-density lipoprotein by troglitazone. Atherosclerosis. 123:1996;227-234.
6. Graslinski M.R., Rowse P.E., Breider M.A. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro. J. Cardiovasc. Pharmacol. 31:1999;909-913.
7. Satoh H., Tsukamoto K., Hashimoto Y. et al. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPAR on vascular endothelial function. Biochem. Biophys. Res. Commun. 254:1999;757-763.
8. Rollins B.J., Yoshimura T., Leonard E.J. et al. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am. J. Pathol. 136:1990;1229-1233.
9. Yu X, Dluz S., Graves D.T. et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc. Natl. Acad. Sci. USA. 89:1992;6953-6957.
10. Valente A.J., Graves D.T., Vialle-Valentin C.E. et al. Purification of a monocyte chemotactic factor secreted by non human monocyte primate vascular cells in culture. Biochemistry. 27:1988;4162-4167.
11. Sica A., Wang J.M., Colotta F. et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis foctor. J. Immunol. 144:1990;3034-3038.
12. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E. et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88:1991;5252-5256.
13. Nelken N.S., Coughlin S.R., Gordon D. et al. Monocyte chemo-attractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1991;1121-1127.
14. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
15. Strieter R.M., Wiggins R., Phan S.H. et al. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biophy. Res. Commun. 162:1989;694-700.
16. Yoshimura T., Yuhki N., Moore S.K. et al. Human monocyte chemoattractant protein-1 (MCP-1): Full-length cDNA cloning, expression in mitogen-stimulated blood monocyte leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244:1989;487-493.
17. Hotomisligil G.S., . Peraldi P, Budavari A. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science. 271:1996;665-668.
18. Stephens J.M., Lee J., Pilch P.F. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT 4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272:1997;971-976.
19. Lehmann J.M., Moore L.B., Smith-Oliver T.A. et al. An antidiabetic thiazolidinedione is a high-affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270:1995;12953-12956.
20. Okuno A., Tamemoto H., Tobe K. et al. Troglitazone increases the number of small adipocytes without a change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101:1998;1354-1361.
21. Shiomi M., Ito T., Tsukada T. et al. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atheroslerosis of WHHL rabbits. Atherosclerosis. 142:1999;345-353.
22. Minamikawa J., Tanaka S., Yamauchi M. et al. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J. Clin Endocrinol. Metab. 83:1998;1818-1820.
23. Hattori Y., Hattori S., Kasai K. Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells. Hypertension. 33:1999;943-948.
24. Law R.E., Meehan W.P., Xi X.P. et al. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98:1996;1897-1905.
25. Martin T., Cardarelli P.M., Parry G.C. et al. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur. J. Immunol. 27:1997;1091-1097.
26. Jiang C., Ting A.T., Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:1998;82-86.
27. Takahara N., Kashiwagi A., Nishio Y. et al. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells. Diabetologia. 40:1997;662-670.
28. Furata T., Saito T., Ootake T. et al. The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis. 21:1993;480-485.
29. Young B.A., Johnson R.J., Alpers C.E. et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 47:1995;835-944.
30. M.Y. Ohta, Y. Nagai, T. Takamura et al., Inhibitory effect of troglitazone on TNF-α-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human mesangial cells, Metabolism (in press).